share_log

今年至少有10家中国药企的ADC达成了对外授权合作

At least 10 Chinese pharmaceutical companies' ADCs reached external licensing cooperation this year

Moomoo 24/7 ·  Dec 17, 2023 05:42
According to incomplete statistics, since this year, up to now, at least 10 Chinese pharmaceutical companies have reached external licensing cooperation for ADC (antibody-conjugated drugs). In addition to Pfizer and Pfizer mentioned above, partners include multinational pharmaceutical companies such as Eisai, BioNTech, GSK, and AstraZeneca. Huajin Securities said in a research report recently released by Huajin Securities that although domestic ADC started relatively late, the domestic ADC technology platform and ongoing research pipeline were quickly widely recognized by foreign pharmaceutical companies as domestic ADC innovation support increased, and the R&D capabilities of domestic ADC innovative pharmaceutical companies continued to increase. (First Finance)
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment